IL33 and neoplasm: Conversely, IL-33 inhibits tumour growth by enhancing the activation of natural killer (NK) cells and cytotoxic CD8+ T cells [7–9], whereas mice lacking ST2 show attenuated SCC progression due to increased NK cell–mediated cytotoxicity [10].